查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386330

臨床試驗影像市場報告：2030 年趨勢、預測與競爭分析

Clinical Trial Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

臨床試驗成像的趨勢和預測

預計到 2030 年，全球臨床試驗影像市場將達到 21 億美元，2024 年至 2030 年複合年成長率為 7.6%。該市場的主要驅動力是 CRO 的崛起、製藥和生物技術行業的顯著成長以及發現藥物和治療方法的研發支出的增加。全球臨床試驗影像市場的未來前景廣闊，為製藥公司、生物技術公司、醫療設備製造商、委外研發機構、學術研究機構和政府研究組織提供了機會。

臨床試驗成像市場洞察

Lucintel 預測，在預測期內，電腦斷層掃描仍將是最大的區隔市場，部分原因是受託研究機構(CRO) 的不斷增加和研發投資的增加。

由於對旨在解決慢性病的新治療方法和藥物的需求不斷增加，製藥公司仍然是市場上最大的部分。

由於領先的外包公司的存在以及該地區研發的不斷增加，預計北美地區在預測期內將出現最高的成長。老年人口增加和慢性病增加等各種因素預計將推動北美市場的發展。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球臨床試驗影像市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球臨床試驗影像市場趨勢（2018-2023）與預測（2024-2030）
  • 依產品和服務分類的全球臨床試驗影像市場
    • 軟體
    • 服務
  • 依模式分類的全球臨床試驗影像市場
    • CT檢查
    • 磁振造影
    • 超音波
    • 正子斷層掃描
    • X光
    • 心臟超音波圖
  • 依治療領域分類的全球臨床試驗影像市場
    • 腫瘤學
    • 感染疾病
    • 神經病學
    • CVS
    • 內分泌學
    • 免疫疾病
  • 依最終用途分類的全球臨床試驗影像市場
    • 製藥公司
    • 生技公司
    • 醫療設備製造商
    • 合約研究組織
    • 學術和政府研究機構
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球臨床試驗影像市場（依地區）
  • 北美臨床試驗影像市場
  • 歐洲臨床試驗影像市場
  • 亞太臨床試驗影像市場
  • 其他區域臨床試驗影像市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依產品和服務分類的全球臨床試驗成像市場成長機會
    • 依模式分類的全球臨床試驗成像市場成長機會
    • 依治療領域分類的全球臨床試驗成像市場成長機會
    • 依最終用途分類的全球臨床試驗成像市場成長機會
    • 依地區分類的全球臨床試驗成像市場成長機會
  • 全球臨床試驗影像市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球臨床試驗影像市場的產能
    • 全球臨床試驗影像市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • ICON
  • Biotelemetry
  • Medpace Holdings
  • Biomedical Systems Corporation
  • Bioclinica
  • IXICO
  • Resonance Health
  • Radiant Sage
  • Intrinsic Imaging
  • Cardiovascular Imaging Technologies
簡介目錄

Clinical Trial Imaging Trends and Forecast

The future of the global clinical trial imaging market looks promising with opportunities in the pharmaceutical company, biotechnology company, medical device manufacturer, contract research organization, academic and government research institute markets. The global clinical trial imaging market is expected to reach an estimated $2.1 billion by 2030 with a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are increasing number of CROs, significantly growing pharmaceutical and biotechnology industries, and increasing R&D spending to discover drugs and therapies.

A more than 150-page report is developed to help in your business decisions.

Clinical Trial Imaging by Segment

The study includes a forecast for the global clinical trial imaging by product & services, modality, therapeutic area, end use, and region.

Clinical Trial Imaging Market by Product & Services [Shipment Analysis by Value from 2018 to 2030]:

  • Software
  • Services

Clinical Trial Imaging Market by Modality [Shipment Analysis by Value from 2018 to 2030]:

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Positron Emission Tomography
  • X-ray
  • Echocardiography

Clinical Trial Imaging Market by Therapeutic Area [Shipment Analysis by Value from 2018 to 2030]:

  • Oncology
  • Infectious Diseases
  • Neurology
  • CVS
  • Endocrinology
  • Immunological Disorder

Clinical Trial Imaging Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Manufacturer
  • Contract Research Organizations
  • Academic and Government Research Institutes
  • Others

Clinical Trial Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Clinical Trial Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies clinical trial imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the clinical trial imaging companies profiled in this report include-

  • Icon
  • Biotelemetry
  • Medpace Holdings
  • Biomedical Systems Corporation
  • Bioclinica
  • Ixico
  • Resonance Health
  • Radiant Sage
  • Intrinsic Imaging
  • Cardiovascular Imaging Technologies

Clinical Trial Imaging Market Insights

Lucintel forecasts that computed tomography will remain the largest segment over the forecast period due to including the increasing presence of contract research organizations (CROs) and rising research and development investments.

Within this market, pharmaceutical companies will remain the largest segment due to increasing demand for new treatments and medications aimed at addressing chronic diseases.

North America is expected to witness highest growth over the forecast period due to the presence of big outsourcing companies and an increase in r&d in the region. various factors such as the increasing geriatric population along with growing chronic diseases are projected to drive the market in north america. north america also performs the maximum number of clinical trials.

Features of the Global Clinical Trial Imaging Market

Market Size Estimates: Clinical trial imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Clinical trial imaging market by various segments, such as by product & services, modality, therapeutic area, end use and region in terms of($B).

Regional Analysis: Clinical trial imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product & services, modalities, therapeutic areas, end uses, and regions for the clinical trial imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the clinical trial imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the clinical trial imaging market size?

Answer: The global clinical trial imaging market is expected to reach an estimated $2.1 billion by 2030.

Q.2 What is the growth forecast for clinical trial imaging market?

Answer: The global clinical trial imaging market is expected to grow with a CAGR of 7.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the clinical trial imaging market?

Answer: The major drivers for this market are increasing number of CROs, significantly growing pharmaceutical and biotechnology industries, and increasing R&D spending to discover drugs and therapies.

Q4. What are the major segments for clinical trial imaging market?

Answer: The future of the clinical trial imaging market looks promising with opportunities in the pharmaceutical company, biotechnology company, medical device manufacturer, contract research organization, academic and government research institute markets.

Q5. Who are the key clinical trial imaging market companies?

Answer: Some of the key clinical trial imaging companies are as follows:

  • ICON
  • Biotelemetry
  • Medpace Holdings
  • Biomedical Systems Corporation
  • Bioclinica
  • IXICO
  • Resonance Health
  • Radiant Sage
  • Intrinsic Imaging
  • Cardiovascular Imaging Technologies

Q6. Which clinical trial imaging market segment will be the largest in future?

Answer: Lucintel forecasts that computed tomography will remain the largest segment over the forecast period due to including the increasing presence of contract research organizations (CROs) and rising research and development investments.

Q7. In clinical trial imaging market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the presence of big outsourcing companies and an increase in r&d in the region. various factors such as the increasing geriatric population along with growing chronic diseases are projected to drive the market in north america. north america also performs the maximum number of clinical trials.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the clinical trial imaging market by product & services (software and services), modality (computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray, and echocardiography), therapeutic area (oncology, infectious diseases, neurology, CVS, endocrinology, and immunological disorder), end use (pharmaceutical companies, biotechnology companies, medical device manufacturer, contract research organizations, academic and government research institutes, and others),and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Clinical Trial Imaging Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Clinical Trial Imaging Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Clinical Trial Imaging Market by Product & Services
    • 3.3.1: Software
    • 3.3.2: Services
  • 3.4: Global Clinical Trial Imaging Market by Modality
    • 3.4.1: Computed Tomography
    • 3.4.2: Magnetic Resonance Imaging
    • 3.4.3: Ultrasound
    • 3.4.4: Positron Emission Tomography
    • 3.4.5: X-ray
    • 3.4.6: Echocardiography
  • 3.5: Global Clinical Trial Imaging Market by Therapeutic Area
    • 3.5.1: Oncology
    • 3.5.2: Infectious Diseases
    • 3.5.3: Neurology
    • 3.5.4: CVS
    • 3.5.5: Endocrinology
    • 3.5.6: Immunological Disorder
  • 3.6: Global Clinical Trial Imaging Market by End Use
    • 3.6.1: Pharmaceutical Companies
    • 3.6.2: Biotechnology Companies
    • 3.6.3: Medical Device Manufacturer
    • 3.6.4: Contract Research Organizations
    • 3.6.5: Academic and Government Research Institutes
    • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Clinical Trial Imaging Market by Region
  • 4.2: North American Clinical Trial Imaging Market
    • 4.2.2: North American Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
  • 4.3: European Clinical Trial Imaging Market
    • 4.3.1: European Clinical Trial Imaging Market by Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, and Echocardiography
    • 4.3.2: European Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
  • 4.4: APAC Clinical Trial Imaging Market
    • 4.4.1: APAC Clinical Trial Imaging Market by Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, and Echocardiography
    • 4.4.2: APAC Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
  • 4.5: ROW Clinical Trial Imaging Market
    • 4.5.1: ROW Clinical Trial Imaging Market by Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, and Echocardiography
    • 4.5.2: ROW Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Clinical Trial Imaging Market by Product & Services
    • 6.1.2: Growth Opportunities for the Global Clinical Trial Imaging Market by Modality
    • 6.1.3: Growth Opportunities for the Global Clinical Trial Imaging Market by Therapeutic Area
    • 6.1.4: Growth Opportunities for the Global Clinical Trial Imaging Market by End Use
    • 6.1.5: Growth Opportunities for the Global Clinical Trial Imaging Market by Region
  • 6.2: Emerging Trends in the Global Clinical Trial Imaging Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Clinical Trial Imaging Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clinical Trial Imaging Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: ICON
  • 7.2: Biotelemetry
  • 7.3: Medpace Holdings
  • 7.4: Biomedical Systems Corporation
  • 7.5: Bioclinica
  • 7.6: IXICO
  • 7.7: Resonance Health
  • 7.8: Radiant Sage
  • 7.9: Intrinsic Imaging
  • 7.10: Cardiovascular Imaging Technologies